The present invention discloses a method of preparing a terpolymer-doped polyaniline super-hydrophobic composite anticorrosive paint. The method includes: firstly by adopting solution polymerization, stirring a hydrophilic vinyl monomer, a fluorine-containing acrylate monomer and an oil-soluble initiator in a solvent evenly and carrying out a reaction for a period of time, then adding a functional acrylic monomer or long-chain acrylate monomer as a third monomer for further reaction for a period of time to obtain a fluorine-containing terpolymer surfactant; then mixing the fluorine-containing terpolymer surfactant with an aniline monomer and an oxidant evenly, and carrying out a reaction for a period of time to obtain super-hydrophobic polyaniline; and finally dispersing the prepared super-hydrophobic polyaniline evenly in a resin matrix to prepare the polyaniline super-hydrophobic composite anticorrosive paint with an excellent anticorrosive performance.

The present invention discloses a method of preparing a terpolymer-doped polyaniline super-hydrophobic composite anticorrosive paint. The method includes: firstly by adopting solution polymerization, stirring a hydrophilic vinyl monomer, a fluorine-containing acrylate monomer and an oil-soluble initiator in a solvent evenly and carrying out a reaction for a period of time, then adding a functional acrylic monomer or long-chain acrylate monomer as a third monomer for further reaction for a period of time to obtain a fluorine-containing terpolymer surfactant; then mixing the fluorine-containing terpolymer surfactant with an aniline monomer and an oxidant evenly, and carrying out a reaction for a period of time to obtain super-hydrophobic polyaniline; and finally dispersing the prepared super-hydrophobic polyaniline evenly in a resin matrix to prepare the polyaniline super-hydrophobic composite anticorrosive paint with an excellent anticorrosive performance.

The present invention addresses the problem of providing an emulsion having excellent emulsion stability and excellent coagulability (salting-out properties) in manufacturing of an acrylic rubber. The present invention provides an acrylic emulsion containing an acrylic polymer having an average particle diameter of 150-300 nm in a step for emulsion-polymerizing a monomer in manufacturing of an acrylic rubber.

The present invention addresses the problem of providing an emulsion having excellent emulsion stability and excellent coagulability (salting-out properties) in manufacturing of an acrylic rubber. The present invention provides an acrylic emulsion containing an acrylic polymer having an average particle diameter of 150-300 nm in a step for emulsion-polymerizing a monomer in manufacturing of an acrylic rubber.

An object of the present invention is to provide a composition for lithography capable of obtaining a film in contact with a resist layer or an underlayer film capable of forming a pattern excellent in exposure sensitivity the like. The object can be achieved by a composition for lithography containing a compound having at least one element selected from the group consisting of iodine, tellurium, and fluorine, or a resin having a constituent unit derived from the compound, wherein a total mass of the atoms in the compound is 15% by mass or more and 75% by mass or less.

An object of the present invention is to provide a composition for lithography capable of obtaining a film in contact with a resist layer or an underlayer film capable of forming a pattern excellent in exposure sensitivity the like. The object can be achieved by a composition for lithography containing a compound having at least one element selected from the group consisting of iodine, tellurium, and fluorine, or a resin having a constituent unit derived from the compound, wherein a total mass of the atoms in the compound is 15% by mass or more and 75% by mass or less.

Provided are a polymer medicament for treating hyperkalemia, and a preparation method thereof. Specifically, a polymer is provided, and the polymer includes repeating units obtained by polymerizing a monomer and a crosslinking agent. A molar ratio of the monomer to the crosslinking reagent ranges from 1:0.02 to 1:0.20. The monomer includes an acidic group and a pKa-reducing group next to the acidic group. The acidic group is selected from the group consisting of sulfonic acid group (—SO.sub.3—), sulfuric acid group (—OSO.sub.3—), carboxylic group (—CO.sub.2—), phosphonic acid group (—OPO.sub.3.sup.2—), phosphate group (—OPO.sub.3.sup.2—), and sulfamic acid group (—NHSO.sub.3—). The pKa-reducing group is selected from the group consisting of nitro, cyano, carbonyl, trifluoromethyl, and halogen atoms. The crosslinking agent has three or four reaction sites. The polymer can be used to treat hyperkalemia.

Provided are a polymer medicament for treating hyperkalemia, and a preparation method thereof. Specifically, a polymer is provided, and the polymer includes repeating units obtained by polymerizing a monomer and a crosslinking agent. A molar ratio of the monomer to the crosslinking reagent ranges from 1:0.02 to 1:0.20. The monomer includes an acidic group and a pKa-reducing group next to the acidic group. The acidic group is selected from the group consisting of sulfonic acid group (—SO.sub.3—), sulfuric acid group (—OSO.sub.3—), carboxylic group (—CO.sub.2—), phosphonic acid group (—OPO.sub.3.sup.2—), phosphate group (—OPO.sub.3.sup.2—), and sulfamic acid group (—NHSO.sub.3—). The pKa-reducing group is selected from the group consisting of nitro, cyano, carbonyl, trifluoromethyl, and halogen atoms. The crosslinking agent has three or four reaction sites. The polymer can be used to treat hyperkalemia.

A fluorine-containing copolymer composition includes repeating units derived from a fluorine-containing monomer represented by Formula (I) and from a monomer having at least two polymerizable groups, in which the latter is 3% by mass or more with respect to a total mass of the fluorine-containing copolymer, and the former is 15% by mass or more with respect to a total solid content in the composition, in the Formula (I), R.sup.1 represents a hydrogen atom or an alkyl group having 1 to 20 carbon atoms; R.sup.2 represents a group having at least one fluorine atom; and L.sub.1 represents a divalent linking group including at least one selected from the group consisting of —O—, —(C═O)O—, —O(C═O)—, —(C═O)NH—, —NH(C═O)—, a divalent aromatic group which may have a substituent, a divalent aliphatic chain group which may have a substituent, and a divalent aliphatic cyclic group which may have a substituent.

A fluorine-containing copolymer composition includes repeating units derived from a fluorine-containing monomer represented by Formula (I) and from a monomer having at least two polymerizable groups, in which the latter is 3% by mass or more with respect to a total mass of the fluorine-containing copolymer, and the former is 15% by mass or more with respect to a total solid content in the composition, in the Formula (I), R.sup.1 represents a hydrogen atom or an alkyl group having 1 to 20 carbon atoms; R.sup.2 represents a group having at least one fluorine atom; and L.sub.1 represents a divalent linking group including at least one selected from the group consisting of —O—, —(C═O)O—, —O(C═O)—, —(C═O)NH—, —NH(C═O)—, a divalent aromatic group which may have a substituent, a divalent aliphatic chain group which may have a substituent, and a divalent aliphatic cyclic group which may have a substituent.